Skip to content
50th_Anniversary_Logo_10OCT25

It’s not just about meeting standards—it’s about setting them.

At Biotics Research, quality isn’t just a commitment—it’s the foundation upon which we’ve built our reputation as the leader in professional-grade nutritional supplements. Our meticulous approach to quality control and manufacturing excellence has established benchmarks that define what true quality means in our industry.

When you choose Biotics Research, you are choosing a partner whose commitment to quality has been validated by the most respected third-party organizations in the world.

Our Journey
Built on Integrity, Founded in Science

Five decades ago, our family founded Biotics Research with a mission: to bridge the best of science and nature for healthcare professionals seeking superior nutritional solutions. Our journey began when a family member became terminally ill, transforming personal adversity into our enduring passion to help others. Today, that founding principle—the best of science and nature—remains stronger than ever.

BillSparks
1976

Pioneering Nutrition Company Becomes Incorporated

Our story actually began in the late 1950s when Frank DeLuca set out to help a family member who had been diagnosed with a terminal illness. Frank began looking for scientific answers in nature to help keep his nephew alive long after medical expectations. It was that illness that inspired his search for medical answers in nature. Bringing several family members together to passionately strive to find holistic remedies, a flagship company in the nutritional supplements industry began.

Biotics Research Corporation incorporated in 1976 with Denis DeLuca as President and Daryl DeLuca as Vice President.

1979

First Company to Manufacture and Market CoQ10 in the United States

In 1979, few people knew about the fat-soluble substance called coenzyme Q10 (CoQ10). Through research networks, Biotics Research became interested in CoQ10 as a nutrient. Renowned biochemist Karl August Folkers had identified the chemical structure and began finding links between CoQ10 and heart health. We took the next step and proved that CoQ10 was part of the diet (beef heart and musculoskeletal tissue). 

Biotics Research scientists developed extraction of CoQ10 from bovine heart tissue, providing a true food source of CoQ. Later, we would become the first company to recognize how CoQ10 is best absorbed by the body and developed their proprietary emulsification process. Note: Even today, a significant amount of CoQ10 in the market is synthetically produced.

Because of Biotics Research Corporation, CoQ10 became available as a dietary supplement in US markets.

1980

Love Canal

Complaints of birth defects in the late 1970s spurred the EPA to commission Biogenics, a mobile genetics toxicology lab (Biotics Research owned 81%, where all of the laboratory work was performed) to conduct genetic testing. In 1980, reports of the Love Canal study were published in national magazines highlighting the link between chemical waste and increased genetic risks.

After being commissioned to perform a risk assessment at Love Canal, Biogenics found 11 of the 36 subjects studied to have damaged chromosomes, which led to an emergency order signed by President Carter and the relocation of residents. The risk assessment study led to the development of the Super Fund to clean up the 52,000 chemical dump sites in the USA.

2000

Formula Patented for Augmentation of Testosterone Levels 

Another Biotics Research patent is filed with the USPTO. b-VITAL® is a patented formula clinically demonstrated to augment testosterone levels and provide a sense of well-being in men. Biotics Research found the combination of the Andean tuber, maca and velvet antler, such as from deer or elk, is useful in raising testosterone levels in men with low normal or low testosterone levels, while enhancing vitality. 

With a catalog of over 300 nutrition products, men’s health is just one of the many categories of nutritional support Biotics Research offers.

Patent (P) US 6,093,421
Daryl L. DeLuca, William S. Sparks,
Denis R. DeLuca

2008

Landmark Research at Boston Children’s Hospital

One of the first companies to bring an emulsified form of vitamin D to the market, Biotics Research pursued validation of their invention through research at Boston Children’s Hospital. The objective of the study, published in The Journal of Clinical Endocrinology & Metabolism, was to compare the safety and efficacy of vitamin D3 in raising serum 25-hydroxyvitamin D[25(OH)D] in infants and toddlers. In this clinical study, levels of 25(OH)D increased from 13.7 ng/ml to 41.2 ng/ml (202%) in a 6-week time period with 50 mcg (2000IU) of the emulsified vitamin D. Biotics Research’s Bio-D-Mulsion® was shown to be safe and effective for infants and toddlers.

This study with Boston Children’s Hospital is one of many research partnerships Biotics Research is proud to have made over the past 50 years.

2017

Patented Formula that Supports Gastroesophageal Health and Comfort with Botanicals 

Patented Formula that Supports Gastroesophageal Health and Comfort with Botanicals

HCl-Ease® is the latest in a long history of patented nutritional formulas created by Biotics Research. Designed and clinically evaluated by Dr. Gary Lasneski, HCl-Ease® is a highly effective and targeted nutritional formula to support gastroesophageal health and comfort.  

Patent (P) US 9,629,887
Gary Lasneski, William S. Sparks, Daryl L. DeLuca, Denis R. DeLuca

2019

Work with Renowned Cardiologist to Patent Formula for Cardiovascular Support

Bio-CardioSirt BP® supplies a unique (two patents issued) combination of 7 key micronutrients that support normal, healthy blood pressure levels. Biotics Research has a long history of 
developing products in partnerships with clinicians. Bio-CardioSirt BP® was developed in collaboration with Mark Houston, MD, ABAAM, Associate Clinical Professor of Medicine, Vanderbilt University School of Medicine and Director of the Hypertension Institute.

Patent (P) US 9,642,885
William S. Sparks, Daryl L. DeLuca, Denis R. DeLuca, Mark Houston

Patent (P) US 10,391,139
William S. Sparks, Daryl L. DeLuca, Denis R. DeLuca, Mark Houston

2025

Introduce Another Revolutionary Product for Cardiovascular Health

Cardio-Lipid, formulated with Mark Houston, MD, provides five key complementary compounds with an established evidence base for their lipid-supportive properties. These nutrients provide support for healthy lipid metabolism and cardiovascular health. The combination of ingredients have been shown to modulate the body’s natural inflammatory response as well as supporting healthy blood pressure and coronary artery calcium scores. 

Biotics Research is proud to continue our research and product development in cardiovascular health.

Placeholder

Trusted by the brands you know

placeholder-09
placeholder-09
placeholder-09
placeholder-09
placeholder-09
placeholder-09

Latest news
from our blog

Casein Hydrolysate & Stress Resilience

Casein Hydrolysate & Stress Resilience

The Biotics Education TeamFeb 18, 2026 7:44:55 AM

Compelling results from a pivotal 2018 preclinical study published in Biomolecules & Therapeutics demonstrated that oral administration of αS1-casein...

Vitamin D & Epigenetics

Vitamin D & Epigenetics

The Biotics Education TeamFeb 10, 2026 1:55:48 PM

A growing body of research reveals that vitamin D signaling is shaped by genetics and environment, while modulating transcriptional and epigenetic...

Is AI Accurate for Food Tracking?

Is AI Accurate for Food Tracking?

The Biotics Education TeamFeb 3, 2026 8:45:57 AM

From bodybuilders looking to bulk up to everyday folks trying to drop a few pounds, people have practiced tracking their food for decades. Tracking...

Frequently
asked questions

Accordion Title

Accordion Title

Accordion Title

Heading Text

Nullam aliquet, magna faucibus tristique cursus, lacus augue venenatis elit, non gravida mi orci in velit.